On October 13, 2021, leading experts from the SITC Immune Effector Cell-related Adverse Events Guideline Expert Panel presented the "SITC Clinical Practice Guideline Webinar – Case Studies in Immune Effector Cell-related Adverse Events." This high-level webinar covered advanced concepts of...
2 attachments
On Monday, June 21, 2021 from 4 – 5 pm ET, leading experts from the SITC Lymphoma Immunotherapy Guideline Expert Panel presented "SITC Clinical Practice Guideline Webinar – Practical Management Pearls for Immunotherapy for the Treatment of Lymphoma." This high-level webinar was designed so that...
On July 7, 2021, leading experts in cancer immunotherapy presented an advanced webinar focused on the "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma." This high-level webinar was designed so that attendees will be able to...
On June 16, 2021, leading experts in cancer immunotherapy presented an advanced webinar focused on "The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma." This high-level webinar was designed so that attendees will be able to...
Immune effector cell (IEC) therapies offer durable and sustained remissions in significant numbers of patients with hematological cancers. While these unique immunotherapies have improved outcomes for pediatric and adult patients in a number of disease states, as ‘living drugs,’ their toxicity...
Immunotherapy has revolutionized the treatment of certain types of melanoma and other skin cancers. This guide, published by Patient Resource Publishing in partnership with the Society for Immunotherapy of Cancer (SITC), provides information on melanoma and other skin cancers, the immune system,...
2020 Immuno Melanoma-Final.pdf
Immunotherapy was approved in 2015 to treat advanced lung cancer. It is very different from other types of cancer treatment because it uses the body's own immune system to recognize and attack cancer cells that have been hiding and targets them for destruction. Immunotherapy is a systemic...
2019 Immunotherapy Lung.pdf
Learning you have head and neck cancer can fell overwhelming. Give yourself time to digest the news, and then focus on learning as much as you can about your exact diagnosis. Knowing ket information will better prepare you to make well-informed decisions with your doctor. This guide, published...
2019 Immunotherapy H&N.pdf
From the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) post-program webinar recording for the 2017 Philadelphia event is provided here. The...
Advances in Cancer Immunotherapy™ Post-program Webinar 2 (Philadelphia).mp4
LUNGevity's Patient Education Series offers several comprehensive booklets and brochures written and illustrated clearly to help patients understand their diagnosis and treatment options as well as the support services available through LUNGevity. These materials will help you learn about lung...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us